Weekly Reports | Feb 02 2024
Our top ten news from 25 January 2024 to 01 February 2024 (ranked according to popularity).
1 – ResMed Recovery Turns Into Hollywood Script
Wednesday 31 January 2024
More troubles for key competitor Philips/Respironics suggests there could be more momentum shifting in ResMed's favour
2 – ResMed Makes A Comeback
Monday 29 January 2024
ResMed's December quarter showed long-awaited margin improvement and relieved market fears of the impact of weight-loss drugs
3 – Uranium Week: Reassessing Uranium Prices
Tuesday 30 January 2024
Brokers have queued up to lift their longer-term uranium price forecasts just as the spot price sees its first weekly drop since November
4 – Spotlight On ASX-Listed Cannabis Companies
Wednesday 31 January 2024
Some cannabis gems are sprouting in the ASX weed patch, but they are hard to find in the haze of hype, Tim Boreham, Editor, The New Criterion reports
5 – Weekly Ratings, Targets, Forecast Changes – 25-01-24
Monday 29 January 2024
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
6 – In Case You Missed It – BC Extra Upgrades & Downgrades – 25-01-24
Thursday 25 January 2024
A summary of the highlights from Broker Call Extra updates throughout the week past
7 – The Market In Numbers – 27 Jan 2024
Saturday 27 January 2024
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
8 – Woodside Energy: Head And Shoulders
Wednesday 31 January 2024
The Chartist reports a small head-and-shoulders pattern should keep momentum positive in the short term for Woodside Energy shares
9 – The Short Report – 25 Jan 2024
Thursday 25 January 2024
FNArena's weekly update on short positions in the Australian share market
10 – Charter Hall Looks Poised
Tuesday 30 January 2024
Michael Gable of Fairmont Equities is signaling momentum seems to have turned for Charter Hall shares, with a fresh Buy signal about to be triggered